Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...

They say that change takes time. Well, that's not the case for RNA. The small biological molecule acts like a switchboard ...

In human cells, only a small proportion of the information written in genes is used to produce proteins. How does the cell ...

RNA-based medicines are one of the most promising ways to fight human disease, as demonstrated by the recent successes of RNA ...

INTEGRA Biosciences offers liquid handling solutions and magnetic modules to streamline every stage of NGS sample preparation ...

RNA-based medicines are one of the most promising ways to fight ... In fact, these changes persisted for over 100 generations—even after SID-1 was restored to the worms. Subscribe to Technology ...

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

UMD researchers have discovered key mechanisms in gene regulation that could improve the design of RNA-based medicines.

Today the Coalition for Epidemic Preparedness Innovations (CEPI) announced an award of $5 million funding award to Ethris, a ...

Akribion Therapeutics ("Akribion"), the early-stage biotech developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion, today announces its exit from stealth and the ...